BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9850016)

  • 1. Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.
    Fizazi K; Dohollou N; Blay JY; Guérin S; Le Cesne A; André F; Pouillart P; Tursz T; Nguyen BB
    J Clin Oncol; 1998 Dec; 16(12):3736-43. PubMed ID: 9850016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?
    Verrill MW; Judson IR; Harmer CL; Fisher C; Thomas JM; Wiltshaw E
    J Clin Oncol; 1997 Jul; 15(7):2611-21. PubMed ID: 9215832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
    Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
    Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
    Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I
    J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli.
    Bacci G; Ferrari S; Bertoni F; Rimondini S; Longhi A; Bacchini P; Forni C; Manfrini M; Donati D; Picci P
    J Clin Oncol; 2000 Jan; 18(1):4-11. PubMed ID: 10623687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
    Smorenburg CH; van Groeningen CJ; Meijer OW; Visser M; Boven E
    Neth J Med; 2007 Apr; 65(4):132-6. PubMed ID: 17452761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.
    Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM
    Tumori; 2014; 100(4):452-8. PubMed ID: 25296596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
    Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
    Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.
    Baldini EH; Demetri GD; Fletcher CD; Foran J; Marcus KC; Singer S
    Ann Surg; 1999 Jul; 230(1):79-86. PubMed ID: 10400040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)-Based Multimodality Therapy.
    Pretz JL; Barysauskas CM; George S; Hornick JL; Raut CP; Chen YE; Marcus KJ; Choy E; Hornicek F; Ready JE; DeLaney TF; Baldini EH
    Oncologist; 2017 Oct; 22(10):1265-1270. PubMed ID: 28550026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
    Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
    J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
    de Alava E; Kawai A; Healey JH; Fligman I; Meyers PA; Huvos AG; Gerald WL; Jhanwar SC; Argani P; Antonescu CR; Pardo-Mindan FJ; Ginsberg J; Womer R; Lawlor ER; Wunder J; Andrulis I; Sorensen PH; Barr FG; Ladanyi M
    J Clin Oncol; 1998 Apr; 16(4):1248-55. PubMed ID: 9552022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
    Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
    J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.
    Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC
    J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.
    Cotterill SJ; Ahrens S; Paulussen M; Jürgens HF; Voûte PA; Gadner H; Craft AW
    J Clin Oncol; 2000 Sep; 18(17):3108-14. PubMed ID: 10963639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
    Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital.
    Marina NM; Pappo AS; Parham DM; Cain AM; Rao BN; Poquette CA; Pratt CB; Greenwald C; Meyer WH
    J Clin Oncol; 1999 Jan; 17(1):180-90. PubMed ID: 10458232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.